Journal of Clinical and Preventive Cardiology

EDITOR«SQ»S PAGE
Year
: 2021  |  Volume : 10  |  Issue : 2  |  Page : 47-

Editor's page April 2021


Ravi R Kasliwal 
 Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India

Correspondence Address:
Dr. Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurgaon - 122 001, Haryana
India




How to cite this article:
Kasliwal RR. Editor's page April 2021.J Clin Prev Cardiol 2021;10:47-47


How to cite this URL:
Kasliwal RR. Editor's page April 2021. J Clin Prev Cardiol [serial online] 2021 [cited 2022 Oct 4 ];10:47-47
Available from: https://www.jcpconline.org/text.asp?2021/10/2/47/319048


Full Text



As India battles the second wave of coronavirus disease 2019 (COVID-19) epidemic, there is gloom all over the land generally. Doctors of all hues are helping patients battling with the disease on every front and newer guidelines are emerging quickly for ready reference. The clinical and scientific communities have risen as one to help save as many lives as possible from the jaws of death and despair. The Journal of Clinical and Preventive Cardiology (JCPC) community continues its singular task nonetheless, with some good contributions this time too, from diverse international and national communities.

The first article “A study of spectrum of rheumatic heart disease in children in a tertiary care hospital in Western India” is from the Department of Cardiology, U N Mehta Institute of Cardiology and Research Center, Ahmedabad, India. This study yet again emphasizes the fact that rheumatic heart disease (RHD) is still widely prevalent in our country and late presentation with severe pulmonary arterial hypertension is quite common. RHD continues to wreak havoc on young children in our region. Sadly, and I quote, “Although there are strategies and treatment available for the prevention and control of rheumatic valve diseases at effective cost, they remain underutilized due to the lack of awareness in most developing countries.” Unquote.

The second article titled “Peripartum cardiomyopathy in the Indian population: A pooled analysis” is a well-articulated analysis of seven Indian studies. The surprising part is that the maternal mortality in this series was 11.7% and fetal mortality was 14.2%. These are very frightening figures and again bring to sharp focus the point-could these have been prevented?

The third study is very timely “Clinical profile of ST-elevation myocardial infarction thrombolysed with tenecteplase in COVID-19 pandemic: A comparative study” by Drs Jena, Manohar, Elamaran and Rudrappa. This observational study demonstrates the difference in risk factors and the high mortality in COVID-positive and negative patients.

The fourth study “Role of NT-pro-BNP in predicting mortality in heart failure,” again from the Stanley Medical College group, is insightful and is a biomarker-based study. The authors have actually given cutoff values of NT-pro-BNP in clinical situations and hypothesized about prognostication. Their observation on right ventricular failure vis-à -vis left ventricular failure in terms of NT-pro-BNP levels is also worth noting. A good read.

The fifth article titled “Exercise tolerance test using Duke Treadmill: An observational study in a private tertiary care hospital” from Lahore, Pakistan talks about the Duke treadmill score and provides a detailed analysis of the associated risk factors.

The sixth article is an interesting case report highlighting the fact that commonly used drugs can cause serious side effects and a judicious use is necessary. It is a well written case report in a review format.

In the end, the JCPC family wishes its readers safety, peace, and good health.